Real Wegovy vs Mounjaro Costs - Updated February 2026
Price Difference Between Mounjaro and Wegovy: Current UK Stock Availability
The price difference between Mounjaro and Wegovy reflects their distinct dosing schedules and manufacturing processes. Wegovy (semaglutide) follows a fixed 5-dose escalation protocol over 16 weeks, while Mounjaro (tirzepatide) uses different dose increments. Both treatments are prescription-only medicines that require clinical assessment through our online platform.
Supply reliability has been a significant concern for patients considering these treatments. EverydayMeds maintains comprehensive stock levels for both medications through direct partnerships with Novo Nordisk for Wegovy and Eli Lilly for Mounjaro. This eliminates the frustrating wait times that many patients experienced with other suppliers, particularly during the widespread shortages of 2023-2024.
Wegovy Pricing Structure vs Mounjaro Cost Analysis
Understanding the price difference between Mounjaro and Wegovy requires examining the complete treatment pathway. Wegovy single pen prices are: 0.25mg starter dose £79.99, 0.5mg £94.99, 1mg £99.99, 1.7mg £139.99, and maintenance 2.4mg £209.99. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices.
Our bundle options provide convenience rather than savings, with the Intro Trio (0.25mg, 0.5mg, 1mg) available for £299.99 covering your first three months. The Ultimate Stability Trio offers three 2.4mg pens for £649.99, ensuring consistent maintenance supply. These bundles eliminate the need for multiple orders and assurance treatment continuity during your weight management journey alongside a reduced-calorie diet and increased physical activity.
Clinical Evidence Behind the Price Difference Between Mounjaro and Wegovy
The pricing reflects the extensive clinical development programmes for both treatments. Wegovy demonstrated significant efficacy in the STEP clinical trial programme, with patients achieving an average of approximately clinically studied weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). These results supported its MHRA licensing and NICE recommendation under TA875.
Mounjaro's clinical programme focused on dual GIP and GLP-1 receptor activation, representing a different mechanism compared to Wegovy's GLP-1-only approach. Both treatments require prescription through clinical assessment, and the price difference between Mounjaro and Wegovy should be considered alongside your individual medical history and treatment goals as determined by your prescriber.
How Wegovy's Mechanism Influences Its Pricing Structure
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones involved in appetite regulation and glucose control. The medication works by binding to GLP-1 receptors in the brain, reducing appetite and promoting feelings of fullness after smaller meals. This mechanism may also help reduce food cravings by affecting the brain's appetite centres. The once-weekly injection schedule using Novo Nordisk's FlexTouch pen technology provides consistent medication levels throughout the week. Understanding this mechanism helps explain the structured dose escalation required, which influences the overall treatment cost compared to other weight management approaches.
Streamlined Ordering Process for Both Treatments
Accessing either treatment through EverydayMeds begins with our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring thorough evaluation for treatment suitability. Once approved, medications ship via next-day delivery using temperature-controlled logistics to maintain the cold-chain integrity required for these biologics. This efficient process eliminates the traditional barriers to accessing weight management treatments, with both options readily available from our GPhC-registered facility. The streamlined approach ensures you can start treatment promptly once medically approved, regardless of which option best suits your needs and budget.
Storage and Practical Considerations Affecting Long-term Costs
The price difference between Mounjaro and Wegovy extends beyond initial purchase costs to practical storage requirements. Wegovy offers superior travel flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. Both require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability reduces the risk of medication waste during travel or temporary storage issues. The FlexTouch pen system provides precise dose delivery with clear graduation markings, and the systematic dose escalation schedule helps manage both effectiveness and potential side effects. These practical advantages should be factored into your total cost of ownership calculation when comparing treatment options.
In-Stock Advantage: Why Availability Matters for Treatment Costs
The Confirmed Availability of both treatments at EverydayMeds eliminates the hidden costs associated with treatment interruptions. Historical supply shortages led to patients switching between treatments or paying premium prices from limited suppliers, disrupting their weight management progress. Our maintained stock levels for all Wegovy doses and Mounjaro strengths ensure treatment continuity without the need to restart dose escalation protocols due to supply gaps.
This reliability translates to better value for money, as consistent treatment adherence typically produces superior outcomes compared to interrupted therapy cycles. The price difference between Mounjaro and Wegovy becomes more meaningful when you can access either treatment without delays, allowing your prescriber to recommend the most suitable option based on medical factors rather than availability constraints.
Making Your Treatment Decision: Beyond Price Comparison
While understanding the price difference between Mounjaro and Wegovy is important for budgeting, your treatment choice should ultimately reflect clinical suitability and lifestyle factors. Both treatments are available through EverydayMeds, and your prescriber can help determine which option aligns with your medical profile, dosing preferences, and weight management goals. Consider factors like injection frequency, dose escalation schedules, storage requirements, and potential side effect profiles alongside pricing when making your decision.
Our clinical team at EverydayMeds provides ongoing support throughout your treatment journey, helping optimise outcomes regardless of which medication you choose. The investment in either treatment represents a commitment to long-term weight management, as clinical evidence shows that sustained results require continued treatment alongside lifestyle modifications. Remember that both options are prescription-only medicines requiring regular review and monitoring to ensure safe, effective treatment tailored to your individual needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
